ProPhase Labs, Inc. Contracts & Agreements

Inducement Option Award Agreement, effective as of January 1, 2024, by and between ProPhase Labs, Inc. and Jed A. Latkin (Filed With SEC on May 9, 2024)

Standstill Agreement dated April 18, 2024 between ProPhase Labs, Inc. and ThinkEquity LLC (Filed With SEC on April 18, 2024)

Latkin Offer Letter, dated as of December 28, 2023, by and between ProPhase Labs, Inc. and Jed A. Latkin (Filed With SEC on January 4, 2024)

Form of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan (Filed With SEC on March 29, 2023)

Form of Incentive Stock Option Agreement pursuant to 2022 Equity Compensation Plan (Filed With SEC on March 29, 2023)

Form of Option Agreement pursuant to 2022 Directors Equity Compensation Plan (Filed With SEC on March 29, 2023)

Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated January 26, 2023 (Filed With SEC on January 30, 2023)

Common Stock Purchase Warrant issued to JXVII Trust, dated January 27, 2023 (Filed With SEC on January 30, 2023)

Asset Purchase Agreement by and among Stella Diagnostics Inc., Stella DX, LLC and ProPhase Labs, Inc., dated December 15, 2022 (Filed With SEC on December 20, 2022)

Separation Agreement and Release, dated October 4, 2022, by and between ProPhase Labs, Inc. and Bill White (Filed With SEC on October 7, 2022)

License Agreement by and between ProPhase BioPharma, Inc. and Global BioLife, Inc., dated July 19, 2022 (effective as of July 18, 2022) (Filed With SEC on July 21, 2022)

Lease Agreement by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common, dated June 10, 2022 (Filed With SEC on June 13, 2022)

Guaranty dated June 10, 2022 (Filed With SEC on June 13, 2022)

First Amendment of Lease, dated June 10, 2022, by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common (Filed With SEC on June 13, 2022)

2022 Equity Compensation Plan (Filed With SEC on May 20, 2022)

2022 Directors Equity Compensation Plan (Filed With SEC on May 20, 2022)

Employment Agreement, dated as of May 9, 2022, by and between ProPhase Labs, Inc. and Bill White (Filed With SEC on May 10, 2022)

Inducement Option Award Agreement, dated May 9, 2022, by and between ProPhase Labs, Inc. and Bill White (Filed With SEC on May 10, 2022)

Letter Agreement, dated February 28, 2022, by and between ProPhase Labs, Inc. and Justin J. Leonard (Filed With SEC on March 2, 2022)

Sales Agreement dated December 28, 2021 between the Registrant and ThinkEquity LLC (Filed With SEC on December 29, 2021)

Stock Purchase Agreement by and among Nebula Genomics, Inc., the Seller Parties Named therein, Kammal Obbad in the capacity as Seller Party Representative, ProPhase Labs, Inc and... (Filed With SEC on August 16, 2021)

Amended and Restated 2010 Equity Compensation Plan (Filed With SEC on May 21, 2021)

Amended and Restated 2010 Directors Equity Compensation Plan (Filed With SEC on May 21, 2021)

Lease agreement by and among ProPhase Diagnostics, Inc., BRG Office L.L.C. and Unit 2 Associates L.L.C. for the corporate headquarters and diagnostic lab facility located at 711... (Filed With SEC on March 31, 2021)

Underwriting Agreement, dated as of January 18, 2021, by and between ProPhase Labs, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc., as representative of... (Filed With SEC on January 20, 2021)

Amendment and Termination Agreement, dated and effective as of January 14, 2021 (Filed With SEC on January 15, 2021)

Form of Securities Purchase Agreement dated January 5, 2021 (Filed With SEC on January 7, 2021)

Form of Warrant (Filed With SEC on January 7, 2021)

Stock Purchase Agreement, dated October 22, 2020, by and among Confucius Plaza Medical Laboratory Corp., Pride Diagnostics LLC, the Members of Pride Diagnostics LLC and ProPhase... (Filed With SEC on October 26, 2020)

Consulting Agreement, dated September 25, 2020, by and between ProPhase Labs, Inc. and Predictive Labs, Inc (Filed With SEC on September 30, 2020)

Amended and Restated Promissory Note and Security Agreement, dated September 25, 2020, by and between ProPhase Labs, Inc. and Predictive Labs, Inc (Filed With SEC on September 30, 2020)

Sales Agreement dated September 23, 2020 between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on September 23, 2020)

Unsecured Convertible Promissory Note and Guaranty issued to JXVII Trust, dated September 15, 2020 (Filed With SEC on September 18, 2020)

Unsecured Convertible Promissory Note and Guaranty issued Justin J. Leonard, dated September 15, 2020 (Filed With SEC on September 18, 2020)

Agreement of Sale and Purchase, dated July 10, 2020, by and between ProPhase Labs, Inc. and Lenape Valley Foundation (Filed With SEC on August 25, 2020)

Description of Common Stock (Filed With SEC on March 26, 2020)

ProPhaseLabs, Inc. STOCKOPTION AMENDMENT AGREEMENT (Filed With SEC on August 20, 2018)

Amended and Restated 2010 Equity Compensation Plan (Filed With SEC on May 24, 2018)

Amended and Restated 2010 Directors Equity Compensation Plan (Filed With SEC on May 24, 2018)

2018 Stock Incentive Plan (Filed With SEC on April 16, 2018)

Amendment No. 2 to Amended and Restated Rights Agreement, by and between ProPhase Labs, Inc., and American Stock Transfer & Trust Company, LLC, dated as of February 20, 2018 (Filed With SEC on February 21, 2018)

Amended and Restated 2015 Executive Employment Agreement with Ted Karkus, effective February 23, 2018 (Filed With SEC on February 21, 2018)

Stock Option Agreement with Ted Karkus pursuant to 2018 Stock Incentive Plan (Filed With SEC on February 21, 2018)

Employment Agreement Termination and Release Agreement, dated September 27, 2017, by and between ProPhase Labs, Inc. and Robert V. Cuddihy, Jr (Filed With SEC on October 2, 2017)

STOCKPURCHASE AGREEMENT (Filed With SEC on June 14, 2017)

PROPHASELABS, INC. AMENDEDAND RESTATED 2010 EQUITY COMPENSATION PLAN OPTIONAWARD AGREEMENT (Filed With SEC on May 15, 2017)

Re:Employment Agreement Termination and Release Agreement (Filed With SEC on April 19, 2017)

ASSETPURCHASE AGREEMENT (ASAMENDED) BYAND BETWEEN ProPhaseLabs, Inc., MedaConsumer Healthcare Inc. AND MylanInc., asBUYER Guarantor DATEDAS OF JANUARY 6, 2017 (Filed With SEC on March 29, 2017)

MANUFACTURINGAGREEMENT (Filed With SEC on March 29, 2017)

VOTINGAGREEMENT (Filed With SEC on January 9, 2017)

AMENDMENTNO. 1 TO AMENDEDAND RESTATED RIGHTS AGREEMENT (Filed With SEC on January 9, 2017)

ProPhaseLabs, Inc. 12%Secured Promissory Note – Series A andWarrant SUBSCRIPTIONAGREEMENT (Filed With SEC on December 16, 2015)

12%SECURED PROMISSORY NOTE –SERIES A (Filed With SEC on December 16, 2015)

WARRANTNO. 2015-[___] PROPHASELABS, INC. (Filed With SEC on December 16, 2015)

SECURITYAGREEMENT (Filed With SEC on December 16, 2015)

DIRECT RESPONSE PRODUCTION AGREEMENT (Filed With SEC on July 6, 2015)

PLAN OF CONVERSION (Filed With SEC on June 19, 2015)

PROPHASE LABS, INC. and AMERICAN STOCK TRANSFER& TRUST COMPANY, LLC, as Rights Agent (Filed With SEC on June 19, 2014)

EXHIBIT 10.1 Investment Agreement by and between ProPhaseLabs, Inc. and Dutchess Opportunity Fund, II, LP, datedas of May 28, 2014 (Filed With SEC on May 29, 2014)

EXHIBIT 10.2 Registration Rights Agreement by andbetween ProPhase Labs, Inc. and Dutchess Opportunity Fund, II, LP, datedas of May 28, 2014 (Filed With SEC on May 29, 2014)

EXHIBIT 10.3 Letter Agreement by and between ProPhaseLabs, Inc. and Dutchess Opportunity Fund, II, LP, datedas of May 28, 2014 (Filed With SEC on May 29, 2014)

AMENDMENT TO AMENDED AND RESTATED 2010EQUITY COMPENSATION PLAN (Filed With SEC on May 9, 2013)

AMENDMENT TO 2010 DIRECTORS’ EQUITYCOMPENSATION PLAN (Filed With SEC on May 9, 2013)

SETTLEMENT AGREEMENT AND MUTUAL GENERALRELEASE (Filed With SEC on March 28, 2013)

INVESTMENT AGREEMENT (Filed With SEC on November 27, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 27, 2012)

REDEMPTION AGREEMENT (Filed With SEC on September 23, 2011)

PROPHASE LABS, INC. AMENDED AND RESTATED 2010 EQUITY COMPENSATION PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on April 25, 2011)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 25, 2011)

AMENDMENT TO 2010 DIRECTORS EQUITY COMPENSATION PLAN (Filed With SEC on May 10, 2010)

THE QUIGLEYCORPORATION 2010 EQUITY COMPENSATIONPLAN OPTION AWARDAGREEMENT (Filed With SEC on May 10, 2010)

THEQUIGLEY CORPORATION 2010DIRECTORSEQUITY COMPENSATION PLAN OPTION AWARDAGREEMENT (Filed With SEC on May 10, 2010)

THEQUIGLEY CORPORATION 2010DIRECTORS EQUITY COMPENSATION PLAN RESTRICTEDSTOCK AWARD AGREEMENT (Filed With SEC on May 10, 2010)

LIMITEDLIABILITY COMPANY OPERATING AGREEMENT OF PHUSIONLABORATORIES, LLC aDelaware limited liability company DatedMarch 22,2010 TABLEOF CONTENTS (Filed With SEC on March 26, 2010)

LicenseAgreement (Filed With SEC on March 26, 2010)

Amendedand Restated License Agreement (Filed With SEC on March 26, 2010)

SHARETRANSFER RESTRICTION AGREEMENT (Filed With SEC on March 26, 2010)

INDEMNIFICATIONAGREEMENT (Filed With SEC on August 19, 2009)

EMPLOYMENTAGREEMENT (Filed With SEC on August 19, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2009)

SECONDAMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 18, 2009)

AGREEMENT ON ASSIGNMENT ANDCOMPENSATION FOR INVENTIONS (Filed With SEC on August 14, 2009)

Category

Industry

Companies

Contracts

ProPhase Labs, Inc. Contracts & Agreements